• CRESTAR final summary report


    CRESTAR project officially ended 31st October 2015. The final summary report is available here.
  • Improving the outcome in treatment-
    resistant schizophrenia

    The faster schizophrenia patients receive effective treatment, the better their prognosis. EU-funded CRESTAR researchers are establishing a profile of individuals unlikely to respond to the drugs used in first-line treatment, for whom the last-resort antipsychotic clozapine should be considered sooner. They are also improving the safety of this drug.

    Read more: http://ec.europa.eu/programmes/horizon2020/en/news/improving-outcome-treatment-resistant-schizophrenia